BRAZIL
May 17, 2016
The Brazilian PTO strengthens its position against ANVISA's issuance of opinions regarding patentability of applications related to pharmaceutical inventions. Within the frame of a litigation raised by a pharmaceutical company against ANVISA, the Brazilian Patent Office has filed an opinion regarding the role that ANVISA is adopting in the examination of patent applications.